Cargando…
The physiology of cardiovascular disease and innovative liposomal platforms for therapy
Heart disease remains the major cause of death in males and females, emphasizing the need for novel strategies to improve patient treatment and survival. A therapeutic approach, still in its infancy, is the development of site-specific drug-delivery systems. Nanoparticle-based delivery systems, such...
Autores principales: | Ruiz-Esparza, Guillermo U, Flores-Arredondo, Jose H, Segura-Ibarra, Victor, Torre-Amione, Guillermo, Ferrari, Mauro, Blanco, Elvin, Serda, Rita E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572823/ https://www.ncbi.nlm.nih.gov/pubmed/23413209 http://dx.doi.org/10.2147/IJN.S30599 |
Ejemplares similares
-
Adjuvant Cationic Liposomes Presenting MPL and IL-12
Induce Cell Death, Suppress Tumor Growth, and Alter the Cellular Phenotype
of Tumors in a Murine Model of Breast Cancer
por: Meraz, Ismail M., et al.
Publicado: (2014) -
Particle platforms for cancer immunotherapy
por: Serda, Rita Elena
Publicado: (2013) -
Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
por: Segura-Ibarra, Victor, et al.
Publicado: (2018) -
A Systematic Review of the Mechanisms Involved in Immune Checkpoint Inhibitors Cardiotoxicity and Challenges to Improve Clinical Safety
por: Rubio-Infante, Nestor, et al.
Publicado: (2022) -
Full Expression of Cardiomyopathy Is Partly Dependent on B‐Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis
por: Cordero‐Reyes, Andrea M., et al.
Publicado: (2016)